Brief: Oragenics Inc Receives NYSE American Notice
20/12/2022 22:24
Dec 20 (Reuters) - Oragenics Inc OGEN.A :
* ORAGENICS, INC. RECEIVES NYSE AMERICAN NOTICE
* ORAGENICS INC - RECEIVED A NOTICE ON DECEMBER 19, 2022
FROM NYSE
AMERICAN STATING THAT CO IS NOT IN COMPLIANCE WITH CONTINUED
LISTING STANDARDS
Source text for Eikon: ID:nBwJXXMqa
Further company coverage: OGEN.A
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Oragenics
See all newsBrief: Oragenics Reports Continued Clinical Progress, Provides Regulatory And NYSE American Listing Update
Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation
Brief: Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing
Brief: Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.
Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing